In vitro study of G protein activation by 35S-GTPγS binding to platelet membrane.: Effects of different modulators

被引:0
作者
Karege, F [1 ]
Lambercy, C [1 ]
Rudolph, W [1 ]
Schwald, M [1 ]
Malafosse, A [1 ]
机构
[1] Univ Hosp Geneva, Div Neuropsychiat, CH-1225 Geneva, Switzerland
关键词
G protein; S-35-GTP gamma S; platelet; GDP; sodium chloride; alpha; 2-adrenoceptor;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of guanine nucleotide triphosphate (GTP)-binding protein by liganded-receptor was investigated in platelet membrane by measuring alpha 2-adrenergic receptor agonist (the bromoxidine or UK-14304)-induced S-35-GTP gamma S binding in the presence or absence of modulators such as magnesium, sodium chloride and guanine nucleotide diphosphate (GDP). In basal conditions, with millimolar levels of magnesium (5mM), results indicated high spontaneous, non-receptor-mediated S-35-GTP gamma S at 37 degrees C. The addition of 100mM NaCl and 2 mu M GDP reduced the absolute levels of bound radioligand, but increased the effect of the agonist. At low temperature (4 degrees C) the presence of GDP was not required for an agonist effect. If magnesium was reduced to picomolar levels (max 1 mu mol) a S-35-GTP gamma S release occurred in the presence of the alpha 2-AR agonist. These data showed, contrary to some cell systems, that platelet alpha 2-adrenoceptor required the presence of magnesium, guanine nucleotide diphosphate and sodium chloride for activation of G-protein, when the reaction was followed at physiological temperature.
引用
收藏
页码:25 / 40
页数:16
相关论文
共 30 条
[1]  
Akkerman JWN, 1996, HAEMOSTASIS, V26, P199
[2]   RECEPTOR-EFFECTOR COUPLING BY G-PROTEINS [J].
BIRNBAUMER, L ;
ABRAMOWITZ, J ;
BROWN, AM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1031 (02) :163-224
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   THE MAMMALIAN BETA-2-ADRENERGIC RECEPTOR - RECONSTITUTION OF FUNCTIONAL INTERACTIONS BETWEEN PURE RECEPTOR AND PURE STIMULATORY NUCLEOTIDE BINDING-PROTEIN OF THE ADENYLATE-CYCLASE SYSTEM [J].
CERIONE, RA ;
CODINA, J ;
BENOVIC, JL ;
LEFKOWITZ, RJ ;
BIRNBAUMER, L ;
CARON, MG .
BIOCHEMISTRY, 1984, 23 (20) :4519-4525
[5]  
DAPRADA M, 1988, EXPERIENTIA, V44, P115
[6]   INHIBITION OF BRAIN ADENYLATE-CYCLASE BY A1 ADENOSINE RECEPTORS - PHARMACOLOGICAL CHARACTERISTICS AND LOCATIONS [J].
EBERSOLT, C ;
PREMONT, J ;
PROCHIANTZ, A ;
PEREZ, M ;
BOCKAERT, J .
BRAIN RESEARCH, 1983, 267 (01) :123-129
[7]   MUSCARINIC CHOLINERGIC RECEPTOR STIMULATION OF SPECIFIC GTP HYDROLYSIS RELATED TO ADENYLATE-CYCLASE ACTIVITY IN CANINE CARDIAC SARCOLEMMA [J].
FLEMING, JW ;
WATANABE, AM .
CIRCULATION RESEARCH, 1988, 63 (02) :340-350
[8]   INTERACTIONS OF PURIFIED BOVINE BRAIN ADENOSINE-A1-RECEPTORS WITH G-PROTEINS - RECIPROCAL MODULATION OF AGONIST AND ANTAGONIST BINDING [J].
FREISSMUTH, M ;
SELZER, E ;
SCHUTZ, W .
BIOCHEMICAL JOURNAL, 1991, 275 :651-656
[9]  
Friedman E, 1996, J NEUROCHEM, V67, P1145
[10]  
GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151